Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.66107965612709e-54,333.3482824427481,40816.268231734735,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.604482145545692e-51,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.010800912804323e-36,50.17767354596623,4104.074932651511,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.886115784532452e-34,0,0,59
3,Nonalcoholic fatty liver disease WP4396,3.2382465271877555e-22,12.369357045143639,612.058546926562,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CYC1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",4.2205146404347085e-20,0,0,50
4,Oxidative phosphorylation WP623,6.304397000933837e-21,36.39678899082569,1692.9252885991114,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",6.162548068412826e-19,0,0,35
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1896634975589737e-15,27.87295081967213,957.8569067453653,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",9.303168550911175e-14,0,0,27
6,Mitochondrial CIV Assembly WP4922,2.6208238334305775e-11,36.8780487804878,898.5317155924962,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",1.7079035314522598e-09,0,0,18
7,mRNA Processing WP411,5.7824234354793574e-06,6.8003003003003,82.01629807701019,"['SF3B5', 'SF3A1', 'NCBP2', 'SNU13', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SNRPB', 'SRSF9']",0.00032298965189606126,0,0,15
8,Mitochondrial complex III assembly WP4921,1.7641269099860555e-05,32.49418084153984,355.65756862196037,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0008622170272556847,0,0,8
9,Pyrimidine metabolism WP4022,0.00019961555482244633,3.836842942767729,32.68651496507947,"['NME2', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'POLD2', 'POLE3', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.008672186881730723,0,0,16
10,Computational Model of Aerobic Glycolysis WP4629,0.000296388285352056,14.20035778175313,115.36143723744995,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.010919478014294786,0,0,7
11,Cellular Proteostasis WP4918,0.00030719759119499394,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.010919478014294786,0,0,5
12,Eukaryotic Transcription Initiation WP405,0.00035521961735377004,7.311290322580645,58.07192901539468,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.011574239198777007,0,0,9
13,7q11.23 copy number variation syndrome WP4932,0.0006839067605338775,3.259152389540126,23.751688903339517,"['ATP5PB', 'CLTC', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.020569811028365085,0,0,16
14,Nucleotide Excision Repair WP4753,0.001171876511448932,6.493106535362578,43.82294321405593,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5']",0.028719837380287855,0,0,8
15,Cholesterol Biosynthesis Pathway WP197,0.0011752363122368432,12.160857908847184,82.04062588176417,"['IDI1', 'NSDHL', 'HMGCS1', 'CYP51A1', 'PMVK', 'MSMO1']",0.028719837380287855,0,0,6
16,Cori Cycle WP1946,0.0011752363122368432,12.160857908847184,82.04062588176417,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.028719837380287855,0,0,6
17,Translation Factors WP107,0.0014668992074588938,4.513203786746388,29.44686968566561,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF3G', 'EIF4B', 'EIF1']",0.033738681771554556,0,0,10
18,DNA Repair Pathways Full Network WP4946,0.0019664166305837,3.3040692446043165,20.58944746411364,"['FEN1', 'RFC3', 'CENPX', 'RPA2', 'RAD23A', 'GTF2H5', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3']",0.04046678434516983,0,0,13
19,Proteasome Degradation WP183,0.0019664166305837,3.3040692446043165,20.58944746411364,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC3', 'PSMA2', 'PSME3', 'PSME1']",0.04046678434516983,0,0,13
20,Base Excision Repair WP4752,0.00226075706450004,5.409728439271859,32.95636609484061,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3']",0.04419780061097578,0,0,8
21,VEGFA-VEGFR2 Signaling Pathway WP3888,0.002505029366988876,1.768916294426102,10.594844227888052,"['YWHAE', 'RPL5', 'SET', 'NOTCH4', 'CLTC', 'CCDC124', 'ARPC5L', 'CRIP2', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'DNAJA1', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'ARF6']",0.046641261071078605,0,0,41
22,DNA Mismatch Repair WP531,0.0061050757713405415,6.07774798927614,30.988217161485185,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.10850384666337054,0,0,6
23,Ciliary landscape WP4352,0.007787385223175398,2.087945237266504,10.137496392133892,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'SNRPB2', 'COPS8', 'DCAF11', 'CALM2']",0.127452879420888,0,0,20
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.00782319464476039,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.127452879420888,0,0,3
25,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.011088730602094074,4.052772808586762,18.244877788868674,"['IDI1', 'NSDHL', 'HMGCS1', 'PMVK', 'CYP51A1', 'MSMO1', 'DHCR24']",0.1734277466167513,0,0,7
26,Glycolysis and Gluconeogenesis WP534,0.016343131971205106,2.7043348281016444,11.125491593969716,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.230375826493145,0,0,10
27,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.01649750164145284,8.092774308652988,33.21716704933258,"['RAB5C', 'RRAS', 'KRAS', 'HRAS']",0.230375826493145,0,0,4
28,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.01649750164145284,8.092774308652988,33.21716704933258,"['EIF5', 'EIF3I', 'EIF3G', 'EIF1']",0.230375826493145,0,0,4
29,Photodynamic therapy-induced unfolded protein response WP3613,0.018946610035867527,5.060267857142857,20.069681438442167,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'HSP90B1']",0.25545256979393804,0,0,5
30,Selenium Micronutrient Network WP15,0.0215127060069746,2.198815947242206,8.441499680335847,"['GPX4', 'HBA1', 'TXN', 'SELENOK', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'SELENOS', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.28004784529813026,0,0,13
31,Melanoma WP4685,0.022203281852281428,2.947505493611134,11.222671880128837,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.28004784529813026,0,0,8
32,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.025566662879172093,3.150765255416418,11.552173706340973,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.31239266205488403,0,0,7
33,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.026640432953211796,12.131016042780749,43.97887793640112,"['IDI1', 'HMGCS1', 'PMVK']",0.3156487662032064,0,0,3
34,Fatty acid transporters WP5061,0.03248979273296154,5.393993458221826,18.48429487374166,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.36295739881679895,0,0,4
35,Glycolysis in senescence WP5049,0.03248979273296154,5.393993458221826,18.48429487374166,"['LDHA', 'PKM', 'PGK1', 'GAPDH']",0.36295739881679895,0,0,4
36,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.039436670550676366,inf,inf,"['ELOB', 'ELOC']",0.4167496806841746,0,0,2
37,Mevalonate pathway WP3963,0.039436670550676366,inf,inf,"['HMGCS1', 'PMVK']",0.4167496806841746,0,0,2
38,Metabolic reprogramming in colon cancer WP4290,0.04123553900371961,2.4929412574891536,7.948630511758918,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'GAPDH']",0.42429199343300966,0,0,8
39,Ferroptosis WP4313,0.042366458561222876,3.0361930294906165,9.59861548638431,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.4247509050625165,0,0,6
40,Androgen receptor signaling pathway WP138,0.044651268562260746,2.279233870967742,7.085847641130356,"['SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'FKBP4', 'RAN']",0.4364661501960988,0,0,9
41,G13 Signaling Pathway WP524,0.04895039524328447,3.3720238095238093,10.173219933766637,"['CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'CALM2']",0.4386955426969198,0,0,5
42,Ras signaling WP4223,0.049070289548315715,1.883029290853032,5.676394674880464,"['RAB5C', 'RASA4B', 'BAD', 'GNG10', 'GNG3', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'ARF6']",0.4386955426969198,0,0,13
43,Leptin signaling pathway WP2034,0.04936727334696796,2.5767604488534723,7.7521002130051215,"['SOCS3', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.4386955426969198,0,0,7
44,Non-small cell lung cancer WP4255,0.04936727334696796,2.5767604488534723,7.7521002130051215,"['GADD45B', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.4386955426969198,0,0,7
45,Alzheimer's disease WP2059,0.056671446047095675,2.1446869070208727,6.156291150524495,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'GAPDH', 'HSD17B10', 'CALM2']",0.4627912679810391,0,0,9
46,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.05681325028923242,6.064171122994653,17.39195606747091,"['NSDHL', 'CYP51A1', 'DHCR24']",0.4627912679810391,0,0,3
47,HIF1A and PPARG regulation of glycolysis WP2456,0.05681325028923242,6.064171122994653,17.39195606747091,"['LDHA', 'TPI1', 'GAPDH']",0.4627912679810391,0,0,3
48,RalA downstream regulated genes WP2290,0.05681325028923242,6.064171122994653,17.39195606747091,"['RAC3', 'KRAS', 'HRAS']",0.4627912679810391,0,0,3
49,Cytosolic DNA-sensing pathway WP4655,0.07920050433596425,2.427882037533512,6.1565567766815725,"['POLR2E', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.631987697864531,0,0,6
50,G Protein Signaling Pathways WP35,0.08378452402548343,2.1793725058483555,5.403769309867287,"['GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.6423480175287064,0,0,7
51,Pancreatic adenocarcinoma pathway WP4263,0.08378452402548343,2.1793725058483555,5.403769309867287,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG']",0.6423480175287064,0,0,7
52,Genotoxicity pathway WP4286,0.09658398987152111,2.5279017857142856,5.908571743203424,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1', 'PHLDA3']",0.6803645057239721,0,0,5
53,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.09658398987152111,2.5279017857142856,5.908571743203424,"['ACLY', 'IDI1', 'HMGCS1', 'CYP51A1', 'DBI']",0.6803645057239721,0,0,5
54,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.09712903887149316,4.041889483065954,9.424533878855078,"['SOCS3', 'CHI3L1', 'BAX']",0.6803645057239721,0,0,3
55,Cell cycle WP179,0.10006813219259747,1.7135754730009667,3.944486240850617,"['YWHAE', 'CDKN2D', 'ANAPC13', 'CCNB1', 'GADD45B', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.6803645057239721,0,0,11
56,Endometrial cancer WP4155,0.10265826271701871,2.2066780404582014,5.023170773319139,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.6803645057239721,0,0,6
57,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.10265826271701871,2.2066780404582014,5.023170773319139,"['BAD', 'STMN1', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.6803645057239721,0,0,6
58,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.10266369779466586,8.080142475512021,18.3928016741863,"['RRAS', 'IKBKG']",0.6803645057239721,0,0,2
59,Peroxiredoxin 2 induced ovarian failure WP4873,0.10266369779466586,8.080142475512021,18.3928016741863,"['STAR', 'BAX']",0.6803645057239721,0,0,2
60,Myometrial relaxation and contraction pathways WP289,0.11470921410388538,1.5195945945945946,3.2904616407285756,"['YWHAE', 'YWHAB', 'GSTO1', 'ACTG1', 'RGS4', 'CNN1', 'CREB3', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'YWHAH']",0.7299354128747938,0,0,15
61,Amyotrophic lateral sclerosis (ALS) WP2447,0.11833430735879029,2.6952126077906633,5.752234725565701,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.7299354128747938,0,0,4
62,Copper homeostasis WP3286,0.11833430735879029,2.6952126077906633,5.752234725565701,"['COX17', 'MT3', 'ATOX1', 'SOD1']",0.7299354128747938,0,0,4
63,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.11833430735879029,2.6952126077906633,5.752234725565701,"['CFL1', 'BANF1', 'KRAS', 'HRAS']",0.7299354128747938,0,0,4
64,EGF/EGFR signaling pathway WP437,0.12055138919695552,1.686846038863976,3.5688249946926387,"['NDUFA13', 'CFL1', 'STMN1', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.7299354128747938,0,0,10
65,DNA Replication WP466,0.12670485474766735,2.2465277777777777,4.6410902238182326,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.7299354128747938,0,0,5
66,Small cell lung cancer WP4658,0.12694528919561632,1.7984681189694618,3.7120365413025467,"['LAMB3', 'GADD45B', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.7299354128747938,0,0,8
67,Synaptic Vesicle Pathway WP2267,0.12694528919561632,1.7984681189694618,3.7120365413025467,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2']",0.7299354128747938,0,0,8
68,TNF-alpha signaling pathway WP231,0.12694528919561632,1.7984681189694618,3.7120365413025467,"['BAD', 'CDC37', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.7299354128747938,0,0,8
69,Regulation of Actin Cytoskeleton WP51,0.14559176900270998,1.655425219941349,3.1899194364324397,"['RRAS', 'CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'RAC3', 'KRAS', 'ARPC5', 'ACTG1']",0.7693638269372078,0,0,9
70,GABA receptor Signaling WP4159,0.14560849921573754,3.0307486631016043,5.839748876049389,"['GABBR1', 'AP2S1', 'AP2M1']",0.7693638269372078,0,0,3
71,Gastric Cancer Network 2 WP2363,0.14560849921573754,3.0307486631016043,5.839748876049389,"['RFC3', 'S100A6', 'COL9A3']",0.7693638269372078,0,0,3
72,Methionine De Novo and Salvage Pathway WP3580,0.14560849921573754,3.0307486631016043,5.839748876049389,"['AHCY', 'ODC1', 'TXN']",0.7693638269372078,0,0,3
73,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.14560849921573754,3.0307486631016043,5.839748876049389,"['BAD', 'KRAS', 'HRAS']",0.7693638269372078,0,0,3
74,TP53 network WP1742,0.14560849921573754,3.0307486631016043,5.839748876049389,"['SUMO1', 'GADD45A', 'BAX']",0.7693638269372078,0,0,3
75,Interferon type I signaling pathways WP585,0.15798227150595195,2.309672486300497,4.2619750257610365,"['SOCS3', 'RPS6', 'RACK1', 'EIF4B']",0.7964577494997181,0,0,4
76,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.15798227150595195,2.309672486300497,4.2619750257610365,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.7964577494997181,0,0,4
77,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.15798227150595195,2.309672486300497,4.2619750257610365,"['CREB3', 'STAR', 'CALM3', 'CALM2']",0.7964577494997181,0,0,4
78,Modulators of TCR signaling and T cell activation WP5072,0.15888415463165734,1.866364198803877,3.4333261213182666,"['FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.7964577494997181,0,0,6
79,Cysteine and methionine catabolism WP4504,0.1786869959704849,4.039180765805877,6.955952484440023,"['AHCY', 'GOT1']",0.81763330228693,0,0,2
80,Dual hijack model of Vif in HIV infection WP3300,0.1786869959704849,4.039180765805877,6.955952484440023,"['ELOB', 'ELOC']",0.81763330228693,0,0,2
81,Glycerophospholipid Biosynthetic Pathway WP2533,0.1786869959704849,4.039180765805877,6.955952484440023,"['PTPMT1', 'CDIPT']",0.81763330228693,0,0,2
82,Homologous recombination WP186,0.1786869959704849,4.039180765805877,6.955952484440023,"['POLD4', 'POLD2']",0.81763330228693,0,0,2
83,Trans-sulfuration pathway WP2333,0.1786869959704849,4.039180765805877,6.955952484440023,"['AHCY', 'GOT1']",0.81763330228693,0,0,2
84,Amino Acid metabolism WP3925,0.19106971565839412,1.7326694752968212,2.867770555084233,"['ACLY', 'LDHA', 'PKM', 'GOT1', 'ODC1', 'PYCR1']",0.81763330228693,0,0,6
85,DNA damage response WP707,0.19106971565839412,1.7326694752968212,2.867770555084233,"['CCNB1', 'GADD45B', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.81763330228693,0,0,6
86,miRNA regulation of DNA damage response WP1530,0.19106971565839412,1.7326694752968212,2.867770555084233,"['CCNB1', 'GADD45B', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.81763330228693,0,0,6
87,Hepatitis B infection WP4666,0.19383906800843362,1.5168010752688172,2.488656493796108,"['CREB3', 'YWHAQ', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.81763330228693,0,0,9
88,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.19865770771677327,inf,inf,['MAP1LC3A'],0.81763330228693,0,0,1
89,Insulin signaling in adipocytes (diabetic condition) WP3635,0.19865770771677327,inf,inf,['RPS6'],0.81763330228693,0,0,1
90,Insulin signaling in adipocytes (normal condition) WP3634,0.19865770771677327,inf,inf,['RPS6'],0.81763330228693,0,0,1
91,MED and Pseudoachondroplasia genes WP4789,0.19865770771677327,inf,inf,['COL9A3'],0.81763330228693,0,0,1
92,miRNA Biogenesis WP2338,0.19865770771677327,inf,inf,['RAN'],0.81763330228693,0,0,1
93,Mitochondrial CII Assembly WP4920,0.19865770771677327,inf,inf,['SDHAF1'],0.81763330228693,0,0,1
94,NLR Proteins WP288,0.19865770771677327,inf,inf,['IKBKG'],0.81763330228693,0,0,1
95,The alternative pathway of fetal androgen synthesis WP4524,0.19865770771677327,inf,inf,['STAR'],0.81763330228693,0,0,1
96,Thermogenesis WP4321,0.22547399303461235,1.6168007149240393,2.4083062436538136,"['CREB3', 'RPS6', 'ZNF516', 'KRAS', 'HRAS', 'ACTG1']",0.9183367841305566,0,0,6
97,Aryl Hydrocarbon Receptor Netpath WP2586,0.24839758759008457,1.7956189909802756,2.5008028141640386,"['CDC37', 'AIP', 'KRAS', 'HRAS']",0.9270013876016044,0,0,4
98,MET in type 1 papillary renal cell carcinoma WP4205,0.24839758759008457,1.7956189909802756,2.5008028141640386,"['BAD', 'RPL11', 'KRAS', 'HRAS']",0.9270013876016044,0,0,4
99,Notch Signaling Pathway Netpath WP61,0.24839758759008457,1.7956189909802756,2.5008028141640386,"['PSENEN', 'NOTCH4', 'SKP1', 'DLL3']",0.9270013876016044,0,0,4
100,Parkinson's disease pathway WP2371,0.24839758759008457,1.7956189909802756,2.5008028141640386,"['PINK1', 'SYT11', 'CYCS', 'PARK7']",0.9270013876016044,0,0,4
101,Canonical and non-canonical Notch signaling WP3845,0.25816594938898374,2.019607843137255,2.7348573857507716,"['RRAS', 'NOTCH4', 'DLL3']",0.9270013876016044,0,0,3
102,IL-2 signaling pathway WP49,0.25816594938898374,2.019607843137255,2.7348573857507716,"['SOCS3', 'RPS6', 'HRAS']",0.9270013876016044,0,0,3
103,MAPK Cascade WP422,0.25816594938898374,2.019607843137255,2.7348573857507716,"['RRAS', 'KRAS', 'HRAS']",0.9270013876016044,0,0,3
104,p38 MAPK Signaling Pathway WP400,0.25816594938898374,2.019607843137255,2.7348573857507716,"['DDIT3', 'HRAS', 'MEF2D']",0.9270013876016044,0,0,3
105,Nanoparticle-mediated activation of receptor signaling WP2643,0.2599361639583549,2.692193529237162,3.6272440356900253,"['KRAS', 'HRAS']",0.9270013876016044,0,0,2
106,"Relationship between inflammation, COX-2 and EGFR WP4483",0.2599361639583549,2.692193529237162,3.6272440356900253,"['KRAS', 'HRAS']",0.9270013876016044,0,0,2
107,Rett syndrome causing genes WP4312,0.2599361639583549,2.692193529237162,3.6272440356900253,"['EIF2B2', 'IMPDH2']",0.9270013876016044,0,0,2
108,SARS-CoV-2 mitochondrial interactions WP5038,0.2599361639583549,2.692193529237162,3.6272440356900253,"['NDUFB9', 'PHB']",0.9270013876016044,0,0,2
109,Serotonin and anxiety WP3947,0.2599361639583549,2.692193529237162,3.6272440356900253,"['POMC', 'CRH']",0.9270013876016044,0,0,2
110,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.26167372168398584,1.5154155495978552,2.0316522953290663,"['POMC', 'CREB3', 'BAD', 'RPS6', 'ZNF516', 'HRAS']",0.9270013876016044,0,0,6
111,Integrated breast cancer pathway WP1984,0.26316407678715625,1.4059398232844187,1.8768981361893549,"['RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU']",0.9270013876016044,0,0,8
112,Pathways in clear cell renal cell carcinoma WP4018,0.29458210476189006,1.347060578931662,1.646374100190552,"['ACLY', 'LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9990754180361097,0,0,8
113,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.29707467617198985,1.615700267618198,1.9610913200743287,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.9990754180361097,0,0,4
114,NO/cGMP/PKG mediated Neuroprotection WP4008,0.29707467617198985,1.615700267618198,1.9610913200743287,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9990754180361097,0,0,4
115,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.29922749444371,1.425958050780634,1.7204913173363605,"['RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9990754180361097,0,0,6
116,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3147316656217584,1.3467501490757305,1.5568901178335057,"['PSMD8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMC3', 'STUB1']",0.9990754180361097,0,0,7
117,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3180937879773264,1.7307104660045836,1.9823713596269656,"['H3F3B', 'H2AFZ', 'H3F3A']",0.9990754180361097,0,0,3
118,Histone Modifications WP2369,0.3180937879773264,1.7307104660045836,1.9823713596269656,"['SET', 'H3F3B', 'H3F3A']",0.9990754180361097,0,0,3
119,Nanomaterial induced apoptosis WP2507,0.3180937879773264,1.7307104660045836,1.9823713596269656,"['ENDOG', 'BAX', 'CYCS']",0.9990754180361097,0,0,3
120,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3180937879773264,1.7307104660045836,1.9823713596269656,"['MAP1LC3A', 'ATG101', 'FTL']",0.9990754180361097,0,0,3
121,Regulation of Microtubule Cytoskeleton WP2038,0.3180937879773264,1.7307104660045836,1.9823713596269656,"['PARD6A', 'CFL2', 'STMN1']",0.9990754180361097,0,0,3
122,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3413397113334544,2.018699910952805,2.1698542589753655,"['H3F3B', 'H3F3A']",0.9990754180361097,0,0,2
123,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3413397113334544,2.018699910952805,2.1698542589753655,"['CD63', 'SOD1']",0.9990754180361097,0,0,2
124,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3413397113334544,2.018699910952805,2.1698542589753655,"['BAD', 'BAX']",0.9990754180361097,0,0,2
125,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3413397113334544,2.018699910952805,2.1698542589753655,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
126,Tumor suppressor activity of SMARCB1 WP4204,0.3413397113334544,2.018699910952805,2.1698542589753655,"['H3F3B', 'H3F3A']",0.9990754180361097,0,0,2
127,IL-3 signaling pathway WP286,0.3467333158403167,1.4684940394128618,1.5554279125853454,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.9990754180361097,0,0,4
128,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.3514221203106554,1.2011985055073027,1.25617394503892,"['YWHAE', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ATP1A3', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9990754180361097,0,0,11
129,Cell Differentiation - Index WP2029,0.35787864777113937,4.036476868327402,4.1477275100762965,['MEF2D'],0.9990754180361097,0,0,1
130,Effects of nitric oxide WP1995,0.35787864777113937,4.036476868327402,4.1477275100762965,['HBA1'],0.9990754180361097,0,0,1
131,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.35787864777113937,4.036476868327402,4.1477275100762965,['GABBR1'],0.9990754180361097,0,0,1
132,Heme Biosynthesis WP561,0.35787864777113937,4.036476868327402,4.1477275100762965,['UROD'],0.9990754180361097,0,0,1
133,Hippo-Yap signaling pathway WP4537,0.35787864777113937,4.036476868327402,4.1477275100762965,['YWHAQ'],0.9990754180361097,0,0,1
134,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.35787864777113937,4.036476868327402,4.1477275100762965,['AHCY'],0.9990754180361097,0,0,1
135,Mitochondrial fatty acid synthesis pathway WP4317,0.35787864777113937,4.036476868327402,4.1477275100762965,['MCAT'],0.9990754180361097,0,0,1
136,Molybdenum cofactor (Moco) biosynthesis WP4507,0.35787864777113937,4.036476868327402,4.1477275100762965,['MOCS2'],0.9990754180361097,0,0,1
137,Nanoparticle triggered autophagic cell death WP2509,0.35787864777113937,4.036476868327402,4.1477275100762965,['MAP1LC3A'],0.9990754180361097,0,0,1
138,Purine metabolism WP4792,0.35787864777113937,4.036476868327402,4.1477275100762965,['APRT'],0.9990754180361097,0,0,1
139,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.35787864777113937,4.036476868327402,4.1477275100762965,['MAS1'],0.9990754180361097,0,0,1
140,TCA cycle in senescence WP5050,0.35787864777113937,4.036476868327402,4.1477275100762965,['GOT1'],0.9990754180361097,0,0,1
141,Pathogenic Escherichia coli infection WP2272,0.36441209045232725,1.3461309523809524,1.3588787251076835,"['TUBA1A', 'YWHAQ', 'ARPC5L', 'ARPC5', 'ACTG1']",0.9990754180361097,0,0,5
142,Endothelin Pathways WP2197,0.37813559089488563,1.51403743315508,1.4724051004338656,"['CNN1', 'RIIAD1', 'CALM2']",0.9990754180361097,0,0,3
143,Kit receptor signaling pathway WP304,0.37813559089488563,1.51403743315508,1.4724051004338656,"['BAD', 'RPS6', 'HRAS']",0.9990754180361097,0,0,3
144,miRNA regulation of prostate cancer signaling pathways WP3981,0.37813559089488563,1.51403743315508,1.4724051004338656,"['BAD', 'KRAS', 'IKBKG']",0.9990754180361097,0,0,3
145,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.37813559089488563,1.51403743315508,1.4724051004338656,"['RPS6', 'PIM2', 'EIF4B']",0.9990754180361097,0,0,3
146,Urea cycle and metabolism of amino groups WP497,0.37813559089488563,1.51403743315508,1.4724051004338656,"['GAMT', 'ODC1', 'PYCR1']",0.9990754180361097,0,0,3
147,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3964864737107563,1.3458221825750818,1.245038071475804,"['BEX3', 'SOCS3', 'SERBP1', 'RNF7']",0.9990754180361097,0,0,4
148,Sleep regulation WP3591,0.3964864737107563,1.3458221825750818,1.245038071475804,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9990754180361097,0,0,4
149,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3964864737107563,1.3458221825750818,1.245038071475804,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9990754180361097,0,0,4
150,DNA damage response (only ATM dependent) WP710,0.4078302326106557,1.26171875,1.1316409567624748,"['BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9990754180361097,0,0,5
151,Biomarkers for urea cycle disorders WP4583,0.4196321680614752,1.6146037399821906,1.4020843349640162,"['GAMT', 'GOT1']",0.9990754180361097,0,0,2
152,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4196321680614752,1.6146037399821906,1.4020843349640162,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
153,Lipid Metabolism Pathway WP3965,0.4196321680614752,1.6146037399821906,1.4020843349640162,"['ACLY', 'PRKAR1A']",0.9990754180361097,0,0,2
154,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4196321680614752,1.6146037399821906,1.4020843349640162,"['YWHAQ', 'ACTG1']",0.9990754180361097,0,0,2
155,Nucleotide metabolism WP404,0.4196321680614752,1.6146037399821906,1.4020843349640162,"['NME2', 'OAZ1']",0.9990754180361097,0,0,2
156,22q11.2 copy number variation syndrome WP4657,0.4214345804886071,1.177623732856291,1.0175737392349193,"['RANBP1', 'CYP26B1', 'MRPL40', 'THAP7', 'DGCR6L', 'EMC10', 'RAN']",0.9990754180361097,0,0,7
157,IL-18 signaling pathway WP4754,0.4244711263200552,1.0808267325471819,0.9261726335831747,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'SOCS3', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'RPS11', 'AARS', 'ITM2C', 'ARF6']",0.9990754180361097,0,0,19
158,ATM Signaling Pathway WP2516,0.4369521955198383,1.345513963161022,1.1139933699395266,"['CCNB1', 'GADD45A', 'IKBKG']",0.9990754180361097,0,0,3
159,CAMKK2  Pathway WP4874,0.4369521955198383,1.345513963161022,1.1139933699395266,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9990754180361097,0,0,3
160,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4369521955198383,1.345513963161022,1.1139933699395266,"['STAR', 'KRAS', 'HRAS']",0.9990754180361097,0,0,3
161,Acute viral myocarditis WP4298,0.44556528587419625,1.24202291909696,1.0040656081251742,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9990754180361097,0,0,4
162,PPAR signaling pathway WP3942,0.44556528587419625,1.24202291909696,1.0040656081251742,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9990754180361097,0,0,4
163,G1 to S cell cycle control WP45,0.45081742544497977,1.187237394957983,0.94586353559001,"['CDKN2D', 'CREB3', 'CCNB1', 'GADD45A', 'RPA2']",0.9990754180361097,0,0,5
164,16p11.2 proximal deletion syndrome WP4949,0.45437804225401446,1.153325673432912,0.9097729723251138,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9990754180361097,0,0,6
165,Exercise-induced Circadian Regulation WP410,0.45437804225401446,1.153325673432912,0.9097729723251138,"['DNAJA1', 'IDI1', 'HSPA8', 'SUMO1', 'GSTP1', 'STBD1']",0.9990754180361097,0,0,6
166,Insulin Signaling WP481,0.4569532605869834,1.130268336314848,0.8851969636219638,"['CAP1', 'SOCS3', 'XBP1', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.9990754180361097,0,0,7
167,Canonical NF-KB pathway WP4562,0.4854860395254051,2.01779359430605,1.4580672287103575,['IKBKG'],0.9990754180361097,0,0,1
168,Gastric acid production WP2596,0.4854860395254051,2.01779359430605,1.4580672287103575,['CCK'],0.9990754180361097,0,0,1
169,Glycerolipids and Glycerophospholipids WP4722,0.4854860395254051,2.01779359430605,1.4580672287103575,['CDIPT'],0.9990754180361097,0,0,1
170,Iron metabolism in placenta WP2007,0.4854860395254051,2.01779359430605,1.4580672287103575,['FTH1'],0.9990754180361097,0,0,1
171,Nanoparticle triggered regulated necrosis WP2513,0.4854860395254051,2.01779359430605,1.4580672287103575,['FTL'],0.9990754180361097,0,0,1
172,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.4854860395254051,2.01779359430605,1.4580672287103575,['IKBKG'],0.9990754180361097,0,0,1
173,Serotonin and anxiety-related events WP3944,0.4854860395254051,2.01779359430605,1.4580672287103575,['CRH'],0.9990754180361097,0,0,1
174,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4854860395254051,2.01779359430605,1.4580672287103575,['DLL3'],0.9990754180361097,0,0,1
175,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.4854860395254051,2.01779359430605,1.4580672287103575,['HMGCS1'],0.9990754180361097,0,0,1
176,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4854860395254051,2.01779359430605,1.4580672287103575,['MEF2D'],0.9990754180361097,0,0,1
177,Statin inhibition of cholesterol production WP430,0.4854860395254051,2.01779359430605,1.4580672287103575,['APOC1'],0.9990754180361097,0,0,1
178,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4854860395254051,2.01779359430605,1.4580672287103575,['IKBKG'],0.9990754180361097,0,0,1
179,Valproic acid pathway WP3871,0.4854860395254051,2.01779359430605,1.4580672287103575,['HSD17B10'],0.9990754180361097,0,0,1
180,Senescence and Autophagy in Cancer WP615,0.4915201197929434,1.0762160549089823,0.7643850410227176,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'SPARC', 'MAP1LC3A', 'HMGA1', 'HRAS', 'GABARAP']",0.9990754180361097,0,0,8
181,Autophagy WP4923,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['MAP1LC3B', 'ATG101']",0.9990754180361097,0,0,2
182,BDNF-TrkB Signaling WP3676,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
183,Galanin receptor pathway WP4970,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['POMC', 'VAMP2']",0.9990754180361097,0,0,2
184,Glycosylation and related congenital defects WP4521,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['DPM2', 'DPM3']",0.9990754180361097,0,0,2
185,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['LDHA', 'RPS6']",0.9990754180361097,0,0,2
186,Imatinib and Chronic Myeloid Leukemia WP3640,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['GADD45A', 'PIM2']",0.9990754180361097,0,0,2
187,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['GOT1', 'HMGA1']",0.9990754180361097,0,0,2
188,PDGF Pathway WP2526,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['ARFIP2', 'HRAS']",0.9990754180361097,0,0,2
189,Unfolded protein response WP4925,0.49283754994259793,1.3452062926684476,0.9518352472424756,"['XBP1', 'DDIT3']",0.9990754180361097,0,0,2
190,Retinoblastoma gene in cancer WP2446,0.4929257205784018,1.121031746031746,0.7930142524529555,"['RFC3', 'CCNB1', 'H2AFZ', 'STMN1', 'RPA2']",0.9990754180361097,0,0,5
191,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.49332839906036247,1.1530521218299987,0.814723802135546,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9990754180361097,0,0,4
192,Fas ligand pathway and stress induction of heat shock proteins WP314,0.49351855051593385,1.2106951871657754,0.8549866832348627,"['ARHGDIB', 'CYCS', 'ACTG1']",0.9990754180361097,0,0,3
193,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.49351855051593385,1.2106951871657754,0.8549866832348627,"['TKFC', 'PIN1', 'IKBKG']",0.9990754180361097,0,0,3
194,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5263073268488853,1.046080964685616,0.671447952492011,"['SPARC', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.9990754180361097,0,0,7
195,Folate Metabolism WP176,0.5392622122149918,1.0759440975319654,0.6644528789413959,"['AHCY', 'GPX4', 'HBA1', 'SOD1']",0.9990754180361097,0,0,4
196,Aryl Hydrocarbon Receptor Pathway WP2873,0.5470941209242164,1.1003889158969373,0.663682434810255,"['CDC37', 'AIP', 'BAX']",0.9990754180361097,0,0,3
197,DNA IR-damage and cellular response via ATR WP4016,0.5470941209242164,1.1003889158969373,0.663682434810255,"['FEN1', 'RPA2', 'IKBKG']",0.9990754180361097,0,0,3
198,Interleukin-11 Signaling Pathway WP2332,0.5470941209242164,1.1003889158969373,0.663682434810255,"['SOCS3', 'RPS6', 'HRAS']",0.9990754180361097,0,0,3
199,Breast cancer pathway WP4262,0.5548678789453829,1.0085049239033124,0.5940348644541643,"['GADD45B', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9990754180361097,0,0,8
200,Adipogenesis WP236,0.5597027190535233,1.0084973166368516,0.5852809084607772,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'HMGA1', 'MEF2D']",0.9990754180361097,0,0,7
201,Alpha 6 Beta 4 signaling pathway WP244,0.5598865354945237,1.1527795445872027,0.6686364952111538,"['LAMB3', 'HRAS']",0.9990754180361097,0,0,2
202,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5598865354945237,1.1527795445872027,0.6686364952111538,"['MAP1LC3A', 'EIF2B2']",0.9990754180361097,0,0,2
203,Notch Signaling WP268,0.5598865354945237,1.1527795445872027,0.6686364952111538,"['NOTCH4', 'DLL3']",0.9990754180361097,0,0,2
204,Pre-implantation embryo WP3527,0.5598865354945237,1.1527795445872027,0.6686364952111538,"['DDIT3', 'HMGA1']",0.9990754180361097,0,0,2
205,Fragile X Syndrome  WP4549,0.5656022714721094,1.0084897229669347,0.5747021371164738,"['DUSP3', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9990754180361097,0,0,6
206,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5829747144529341,1.0084745762711864,0.54418444352502,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9990754180361097,0,0,4
207,Oncostatin M Signaling Pathway WP2374,0.5829747144529341,1.0084745762711864,0.54418444352502,"['SOCS3', 'RPS6', 'KRAS', 'HRAS']",0.9990754180361097,0,0,4
208,Prolactin Signaling Pathway WP2037,0.5829747144529341,1.0084745762711864,0.54418444352502,"['SOCS3', 'RPS6', 'PPIB', 'HRAS']",0.9990754180361097,0,0,4
209,ACE Inhibitor Pathway WP554,0.5877523066493601,1.3448991696322656,0.7147462158873015,['MAS1'],0.9990754180361097,0,0,1
210,Alanine and aspartate metabolism WP106,0.5877523066493601,1.3448991696322656,0.7147462158873015,['GOT1'],0.9990754180361097,0,0,1
211,Cannabinoid receptor signaling WP3869,0.5877523066493601,1.3448991696322656,0.7147462158873015,['PRKAR1A'],0.9990754180361097,0,0,1
212,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5877523066493601,1.3448991696322656,0.7147462158873015,['STAR'],0.9990754180361097,0,0,1
213,Dopamine metabolism WP2436,0.5877523066493601,1.3448991696322656,0.7147462158873015,['SOD1'],0.9990754180361097,0,0,1
214,Ebstein-Barr virus LMP1 signaling WP262,0.5877523066493601,1.3448991696322656,0.7147462158873015,['IKBKG'],0.9990754180361097,0,0,1
215,Genes targeted by miRNAs in adipocytes WP1992,0.5877523066493601,1.3448991696322656,0.7147462158873015,['TMSB4X'],0.9990754180361097,0,0,1
216,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5877523066493601,1.3448991696322656,0.7147462158873015,['IKBKG'],0.9990754180361097,0,0,1
217,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5877523066493601,1.3448991696322656,0.7147462158873015,['VEGFB'],0.9990754180361097,0,0,1
218,PPAR-alpha pathway WP2878,0.5877523066493601,1.3448991696322656,0.7147462158873015,['DBI'],0.9990754180361097,0,0,1
219,Purine metabolism and related disorders WP4224,0.5877523066493601,1.3448991696322656,0.7147462158873015,['APRT'],0.9990754180361097,0,0,1
220,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5877523066493601,1.3448991696322656,0.7147462158873015,['BAX'],0.9990754180361097,0,0,1
221,Sulfation Biotransformation Reaction WP692,0.5877523066493601,1.3448991696322656,0.7147462158873015,['SULT4A1'],0.9990754180361097,0,0,1
222,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5877523066493601,1.3448991696322656,0.7147462158873015,['ACLY'],0.9990754180361097,0,0,1
223,Vitamin D in inflammatory diseases WP4482,0.5877523066493601,1.3448991696322656,0.7147462158873015,['IKBKG'],0.9990754180361097,0,0,1
224,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5920009711800269,0.9735056443155882,0.5103574170130033,"['RAB3A', 'BAD', 'CFL1', 'RPS6', 'RACK1', 'IKBKG', 'HRAS']",0.9990754180361097,0,0,7
225,IL-6 signaling pathway WP364,0.5971842870342835,1.0084670231729056,0.5198945251565483,"['SOCS3', 'BAD', 'NR2F6']",0.9990754180361097,0,0,3
226,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5971842870342835,1.0084670231729056,0.5198945251565483,"['IFI27L2', 'KRAS', 'HRAS']",0.9990754180361097,0,0,3
227,Oxidative Damage WP3941,0.5971842870342835,1.0084670231729056,0.5198945251565483,"['BAD', 'GADD45A', 'CYCS']",0.9990754180361097,0,0,3
228,Gastrin signaling pathway WP4659,0.6105381837747496,0.9602465986394558,0.4737995399397484,"['BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.9990754180361097,0,0,5
229,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6188229121739433,0.9483901766297141,0.455166715070404,"['LAMB3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'RAB14', 'CDC37', 'KRAS', 'IKBKG', 'PELO', 'HRAS', 'EIF4B']",0.9990754180361097,0,0,16
230,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6203346745742,1.008459483526269,0.4815355196863642,"['RAB3A', 'NEFL']",0.9990754180361097,0,0,2
231,Oxidative Stress WP408,0.6203346745742,1.008459483526269,0.4815355196863642,"['TXN2', 'SOD1']",0.9990754180361097,0,0,2
232,Apoptosis WP254,0.6241851501425061,0.9489426457469696,0.4472444878976456,"['BAD', 'CYCS', 'BAX', 'IKBKG']",0.9990754180361097,0,0,4
233,Calcium Regulation in the Cardiac Cell WP536,0.6273216557437867,0.9375325894253832,0.4371675672455521,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ANXA6', 'CALM3', 'CALM2', 'YWHAH']",0.9990754180361097,0,0,10
234,Airway smooth muscle cell contraction WP4962,0.6697062617322325,1.0084519572953736,0.4043046036249915,['CALM2'],0.9990754180361097,0,0,1
235,Apoptosis Modulation by HSP70 WP384,0.6697062617322325,1.0084519572953736,0.4043046036249915,['CYCS'],0.9990754180361097,0,0,1
236,Cancer immunotherapy by CTLA4 blockade WP4582,0.6697062617322325,1.0084519572953736,0.4043046036249915,['HLA-DRB1'],0.9990754180361097,0,0,1
237,Cell Differentiation - Index expanded WP2023,0.6697062617322325,1.0084519572953736,0.4043046036249915,['MEF2D'],0.9990754180361097,0,0,1
238,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6697062617322325,1.0084519572953736,0.4043046036249915,['CCK'],0.9990754180361097,0,0,1
239,EPO Receptor Signaling WP581,0.6697062617322325,1.0084519572953736,0.4043046036249915,['EPOR'],0.9990754180361097,0,0,1
240,Ethanol effects on histone modifications WP3996,0.6697062617322325,1.0084519572953736,0.4043046036249915,['AHCY'],0.9990754180361097,0,0,1
241,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6697062617322325,1.0084519572953736,0.4043046036249915,['RPS6'],0.9990754180361097,0,0,1
242,Glutathione metabolism WP100,0.6697062617322325,1.0084519572953736,0.4043046036249915,['GPX4'],0.9990754180361097,0,0,1
243,IL17 signaling pathway WP2112,0.6697062617322325,1.0084519572953736,0.4043046036249915,['IKBKG'],0.9990754180361097,0,0,1
244,Leptin Insulin Overlap WP3935,0.6697062617322325,1.0084519572953736,0.4043046036249915,['SOCS3'],0.9990754180361097,0,0,1
245,NOTCH1 regulation of endothelial cell calcification WP3413,0.6697062617322325,1.0084519572953736,0.4043046036249915,['DLL3'],0.9990754180361097,0,0,1
246,PDGFR-beta pathway WP3972,0.6697062617322325,1.0084519572953736,0.4043046036249915,['HRAS'],0.9990754180361097,0,0,1
247,Physiological and pathological hypertrophy of the heart WP1528,0.6697062617322325,1.0084519572953736,0.4043046036249915,['CALM2'],0.9990754180361097,0,0,1
248,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6697062617322325,1.0084519572953736,0.4043046036249915,['ANAPC11'],0.9990754180361097,0,0,1
249,Role of Osx and miRNAs in tooth development WP3971,0.6697062617322325,1.0084519572953736,0.4043046036249915,['NOTCH4'],0.9990754180361097,0,0,1
250,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6697062617322325,1.0084519572953736,0.4043046036249915,['IDH3B'],0.9990754180361097,0,0,1
251,Trans-sulfuration and one-carbon metabolism WP2525,0.6697062617322325,1.0084519572953736,0.4043046036249915,['AHCY'],0.9990754180361097,0,0,1
252,Common Pathways Underlying Drug Addiction WP2636,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['CALM2', 'ACTG1']",0.9990754180361097,0,0,2
253,Integrated Cancer Pathway WP1971,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['BAD', 'BAX']",0.9990754180361097,0,0,2
254,One-carbon metabolism and related pathways WP3940,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['GPX4', 'SOD1']",0.9990754180361097,0,0,2
255,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
256,Type 2 papillary renal cell carcinoma WP4241,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['ELOB', 'ELOC']",0.9990754180361097,0,0,2
257,Urea cycle and associated pathways WP4595,0.6741566420486051,0.8962105471455427,0.35336935569181416,"['GOT1', 'PYCR1']",0.9990754180361097,0,0,2
258,Chemokine signaling pathway WP3929,0.6794129156776704,0.876358695652174,0.3387356078765461,"['GNG10', 'GNG3', 'KRAS', 'IKBKG', 'HRAS']",0.9990754180361097,0,0,5
259,ErbB signaling pathway WP673,0.685913483445954,0.8640183346065698,0.3257381752289453,"['BAD', 'KRAS', 'HRAS']",0.9990754180361097,0,0,3
260,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.685913483445954,0.8640183346065698,0.3257381752289453,"['NDUFA13', 'COPS6', 'IKBKG']",0.9990754180361097,0,0,3
261,AGE/RAGE pathway WP2324,0.721597477627033,0.8064113980409617,0.2631222056129134,"['CYCS', 'SOD1']",0.9990754180361097,0,0,2
262,Bladder cancer WP2828,0.721597477627033,0.8064113980409617,0.2631222056129134,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
263,IL-5 signaling pathway WP127,0.721597477627033,0.8064113980409617,0.2631222056129134,"['RPS6', 'KRAS']",0.9990754180361097,0,0,2
264,Joubert Syndrome WP4656,0.721597477627033,0.8064113980409617,0.2631222056129134,"['PDE6G', 'ARL2']",0.9990754180361097,0,0,2
265,Oxidation by Cytochrome P450 WP43,0.721597477627033,0.8064113980409617,0.2631222056129134,"['CYP26B1', 'CYP51A1']",0.9990754180361097,0,0,2
266,Type II interferon signaling (IFNG) WP619,0.721597477627033,0.8064113980409617,0.2631222056129134,"['SOCS3', 'HLA-B']",0.9990754180361097,0,0,2
267,Head and Neck Squamous Cell Carcinoma WP4674,0.7244304579070233,0.8062388591800357,0.25990682448858426,"['RPS6', 'KRAS', 'HRAS']",0.9990754180361097,0,0,3
268,Cytokines and Inflammatory Response WP530,0.7353794907903064,0.8065836298932384,0.2479184803071815,['HLA-DRB1'],0.9990754180361097,0,0,1
269,Energy Metabolism WP1541,0.7353794907903064,0.8065836298932384,0.2479184803071815,['MEF2D'],0.9990754180361097,0,0,1
270,ERK Pathway in Huntington's Disease WP3853,0.7353794907903064,0.8065836298932384,0.2479184803071815,['HRAS'],0.9990754180361097,0,0,1
271,Estrogen signaling pathway WP712,0.7353794907903064,0.8065836298932384,0.2479184803071815,['IKBKG'],0.9990754180361097,0,0,1
272,Fatty Acid Biosynthesis WP357,0.7353794907903064,0.8065836298932384,0.2479184803071815,['ACLY'],0.9990754180361097,0,0,1
273,Hedgehog Signaling Pathway Netpath WP47,0.7353794907903064,0.8065836298932384,0.2479184803071815,['SAP18'],0.9990754180361097,0,0,1
274,IL-7 signaling pathway WP205,0.7353794907903064,0.8065836298932384,0.2479184803071815,['BAD'],0.9990754180361097,0,0,1
275,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7353794907903064,0.8065836298932384,0.2479184803071815,['SUPT4H1'],0.9990754180361097,0,0,1
276,Intraflagellar transport proteins binding to dynein WP4532,0.7353794907903064,0.8065836298932384,0.2479184803071815,['DYNLL1'],0.9990754180361097,0,0,1
277,MAPK pathway in congenital thyroid cancer WP4928,0.7353794907903064,0.8065836298932384,0.2479184803071815,['KRAS'],0.9990754180361097,0,0,1
278,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7353794907903064,0.8065836298932384,0.2479184803071815,['SPARC'],0.9990754180361097,0,0,1
279,Osteoclast Signaling WP12,0.7353794907903064,0.8065836298932384,0.2479184803071815,['ATP6V1G1'],0.9990754180361097,0,0,1
280,Overview of nanoparticle effects WP3287,0.7353794907903064,0.8065836298932384,0.2479184803071815,['BAX'],0.9990754180361097,0,0,1
281,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7353794907903064,0.8065836298932384,0.2479184803071815,['LDHA'],0.9990754180361097,0,0,1
282,Resistin as a regulator of inflammation WP4481,0.7353794907903064,0.8065836298932384,0.2479184803071815,['IKBKG'],0.9990754180361097,0,0,1
283,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7353794907903064,0.8065836298932384,0.2479184803071815,['CDC37'],0.9990754180361097,0,0,1
284,Splicing factor NOVA regulated synaptic proteins WP4148,0.7353794907903064,0.8065836298932384,0.2479184803071815,['APLP2'],0.9990754180361097,0,0,1
285,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7353794907903064,0.8065836298932384,0.2479184803071815,['IKBKG'],0.9990754180361097,0,0,1
286,TLR4 Signaling and Tolerance WP3851,0.7353794907903064,0.8065836298932384,0.2479184803071815,['IKBKG'],0.9990754180361097,0,0,1
287,Ebola Virus Pathway on Host WP4217,0.7396229428107723,0.8058928571428572,0.24306918019649199,"['SOCS3', 'CLTC', 'HLA-B', 'HLA-DRB1', 'ACTG1']",0.9990754180361097,0,0,5
288,TGF-beta Signaling Pathway WP366,0.7396229428107723,0.8058928571428572,0.24306918019649199,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.9990754180361097,0,0,5
289,Hippo-Merlin Signaling Dysregulation WP4541,0.7591494601070469,0.7556818181818182,0.20823311539808326,"['PRKAR1A', 'KRAS', 'HRAS']",0.9990754180361097,0,0,3
290,IL-4 signaling pathway WP395,0.7630663178941784,0.7329393669553954,0.19819437915374827,"['SOCS3', 'BAD']",0.9990754180361097,0,0,2
291,PI3K-Akt signaling pathway WP4172,0.7709396251724497,0.8382132132132132,0.21805715711563503,"['LAMB3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'CDC37', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS', 'EIF4B']",0.9990754180361097,0,0,15
292,Focal Adhesion WP306,0.7787978554956311,0.7829954283442655,0.19575180043538662,"['LAMB3', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9990754180361097,0,0,7
293,Fatty acid beta-oxidation WP143,0.7880039630876204,0.6720047449584816,0.16010658190767144,['TPI1'],0.9990754180361097,0,0,1
294,Gastric Cancer Network 1 WP2361,0.7880039630876204,0.6720047449584816,0.16010658190767144,['H3F3A'],0.9990754180361097,0,0,1
295,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7880039630876204,0.6720047449584816,0.16010658190767144,['BAX'],0.9990754180361097,0,0,1
296,miRNAs involvement in the immune response in sepsis WP4329,0.7880039630876204,0.6720047449584816,0.16010658190767144,['IKBKG'],0.9990754180361097,0,0,1
297,MTHFR deficiency WP4288,0.7880039630876204,0.6720047449584816,0.16010658190767144,['CYCS'],0.9990754180361097,0,0,1
298,Neovascularisation processes WP4331,0.7880039630876204,0.6720047449584816,0.16010658190767144,['NOTCH4'],0.9990754180361097,0,0,1
299,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7880039630876204,0.6720047449584816,0.16010658190767144,['OMG'],0.9990754180361097,0,0,1
300,One-carbon metabolism WP241,0.7880039630876204,0.6720047449584816,0.16010658190767144,['AHCY'],0.9990754180361097,0,0,1
301,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7880039630876204,0.6720047449584816,0.16010658190767144,['YWHAQ'],0.9990754180361097,0,0,1
302,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.7880039630876204,0.6720047449584816,0.16010658190767144,['HLA-DRB1'],0.9990754180361097,0,0,1
303,Phosphoinositides metabolism WP4971,0.7880039630876204,0.6720047449584816,0.16010658190767144,['PIP4P1'],0.9990754180361097,0,0,1
304,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7880039630876204,0.6720047449584816,0.16010658190767144,['GSTP1'],0.9990754180361097,0,0,1
305,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7880039630876204,0.6720047449584816,0.16010658190767144,['BAX'],0.9990754180361097,0,0,1
306,Transcriptional cascade regulating adipogenesis WP4211,0.7880039630876204,0.6720047449584816,0.16010658190767144,['DDIT3'],0.9990754180361097,0,0,1
307,Proximal tubule transport WP4917,0.7890059663248603,0.7324628983861812,0.17358008038497819,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9990754180361097,0,0,4
308,p53 transcriptional gene network WP4963,0.7902390760639103,0.7110726643598616,0.16740054985291902,"['SIVA1', 'GADD45A', 'BAX']",0.9990754180361097,0,0,3
309,Cardiac Hypertrophic Response WP2795,0.7990616271632784,0.6717126743840902,0.15067671023386764,"['IKBKG', 'CALM2']",0.9990754180361097,0,0,2
310,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7990616271632784,0.6717126743840902,0.15067671023386764,"['NABP2', 'BAX']",0.9990754180361097,0,0,2
311,MECP2 and Associated Rett Syndrome WP3584,0.8301196218276605,0.6199054729776012,0.11541738929548492,"['GAMT', 'RPS6']",0.9990754180361097,0,0,2
312,Tryptophan metabolism WP465,0.8301196218276605,0.6199054729776012,0.11541738929548492,"['DHCR24', 'HSD17B10']",0.9990754180361097,0,0,2
313,Cancer immunotherapy by PD-1 blockade WP4585,0.8301705119422647,0.5758769700050839,0.10718461915731795,['HLA-DRB1'],0.9990754180361097,0,0,1
314,Genes related to primary cilium development (based on CRISPR) WP4536,0.8301705119422647,0.5758769700050839,0.10718461915731795,['DYNLL1'],0.9990754180361097,0,0,1
315,Heart Development WP1591,0.8301705119422647,0.5758769700050839,0.10718461915731795,['VEGFB'],0.9990754180361097,0,0,1
316,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8301705119422647,0.5758769700050839,0.10718461915731795,['HRAS'],0.9990754180361097,0,0,1
317,Striated Muscle Contraction Pathway WP383,0.8301705119422647,0.5758769700050839,0.10718461915731795,['ACTG1'],0.9990754180361097,0,0,1
318,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8301705119422647,0.5758769700050839,0.10718461915731795,['CALM2'],0.9990754180361097,0,0,1
319,Toll-like Receptor Signaling related to MyD88 WP3858,0.8301705119422647,0.5758769700050839,0.10718461915731795,['IKBKG'],0.9990754180361097,0,0,1
320,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8301705119422647,0.5758769700050839,0.10718461915731795,['PPIB'],0.9990754180361097,0,0,1
321,Circadian rhythm related genes WP3594,0.8304064875208139,0.7589474574837126,0.14104276064484397,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'OPRL1', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9990754180361097,0,0,10
322,Endoderm differentiation WP2853,0.8424204389473892,0.635941457922882,0.10904873285986351,"['TCEAL2', 'NABP2', 'NME1']",0.9990754180361097,0,0,3
323,Vitamin B12 metabolism WP1533,0.8567796341802377,0.5754993003434677,0.08895753372895646,"['HBA1', 'SOD1']",0.9990754180361097,0,0,2
324,MAPK Signaling Pathway WP382,0.8584378649796272,0.7310232368528332,0.11158410146688832,"['HSPA8', 'DUSP3', 'RRAS', 'GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9990754180361097,0,0,10
325,Melatonin metabolism and effects WP3298,0.8639559277819027,0.5037811387900356,0.07366968973402056,['CALM2'],0.9990754180361097,0,0,1
326,Corticotropin-releasing hormone signaling pathway WP2355,0.8640151222626433,0.6040106951871658,0.08828522792043457,"['POMC', 'STAR', 'CRH']",0.9990754180361097,0,0,3
327,Male infertility WP4673,0.8640151222626433,0.6040106951871658,0.08828522792043457,"['PIWIL1', 'CYP26B1', 'HMGA1']",0.9990754180361097,0,0,3
328,Metapathway biotransformation Phase I and II WP702,0.8678049506951268,0.6705391718796545,0.09507460976971446,"['CYP26B1', 'GPX4', 'GSTO1', 'GSTP1', 'CYP51A1', 'SULT4A1']",0.9990754180361097,0,0,6
329,3q29 copy number variation syndrome WP4906,0.8795617295913684,0.5370139507272188,0.06891582199559064,"['NCBP2', 'DYNLL1']",0.9990754180361097,0,0,2
330,Glioblastoma signaling pathways WP2261,0.8795617295913684,0.5370139507272188,0.06891582199559064,"['KRAS', 'HRAS']",0.9990754180361097,0,0,2
331,Prostaglandin Synthesis and Regulation WP98,0.8795617295913684,0.5370139507272188,0.06891582199559064,"['ANXA6', 'S100A6']",0.9990754180361097,0,0,2
332,7-oxo-C and 7beta-HC pathways WP5064,0.8910248754682701,0.44770660340055357,0.05165770116077889,['ACOT4'],0.9990754180361097,0,0,1
333,Blood Clotting Cascade WP272,0.8910248754682701,0.44770660340055357,0.05165770116077889,['F8A1'],0.9990754180361097,0,0,1
334,Cardiac Progenitor Differentiation WP2406,0.8910248754682701,0.44770660340055357,0.05165770116077889,['MESP1'],0.9990754180361097,0,0,1
335,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8910248754682701,0.44770660340055357,0.05165770116077889,['IKBKG'],0.9990754180361097,0,0,1
336,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8910248754682701,0.44770660340055357,0.05165770116077889,['DDIT3'],0.9990754180361097,0,0,1
337,Pathways affected in adenoid cystic carcinoma WP3651,0.8910248754682701,0.44770660340055357,0.05165770116077889,['HRAS'],0.9990754180361097,0,0,1
338,Pregnane X receptor pathway WP2876,0.8910248754682701,0.44770660340055357,0.05165770116077889,['PSMC5'],0.9990754180361097,0,0,1
339,Prion disease pathway WP3995,0.8910248754682701,0.44770660340055357,0.05165770116077889,['HSP90B1'],0.9990754180361097,0,0,1
340,Target Of Rapamycin (TOR) Signaling WP1471,0.8910248754682701,0.44770660340055357,0.05165770116077889,['IDI1'],0.9990754180361097,0,0,1
341,White fat cell differentiation WP4149,0.8910248754682701,0.44770660340055357,0.05165770116077889,['DDIT3'],0.9990754180361097,0,0,1
342,Glycogen Synthesis and Degradation WP500,0.8989530808426445,0.5033392698130009,0.0536179319637773,"['CALM3', 'CALM2']",0.9990754180361097,0,0,2
343,Integrin-mediated Cell Adhesion WP185,0.8989530808426445,0.5033392698130009,0.0536179319637773,"['RAC3', 'HRAS']",0.9990754180361097,0,0,2
344,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8989530808426445,0.5033392698130009,0.0536179319637773,"['IKBKG', 'CALM2']",0.9990754180361097,0,0,2
345,Neural Crest Differentiation WP2064,0.8989530808426445,0.5033392698130009,0.0536179319637773,"['NOTCH4', 'DLL3']",0.9990754180361097,0,0,2
346,Prader-Willi and Angelman Syndrome WP3998,0.8989530808426445,0.5033392698130009,0.0536179319637773,"['POMC', 'FEZ1']",0.9990754180361097,0,0,2
347,B Cell Receptor Signaling Pathway WP23,0.8995174544264155,0.5488575595527467,0.058122270844032924,"['IKBKG', 'HRAS', 'MEF2D']",0.9990754180361097,0,0,3
348,Ectoderm Differentiation WP2858,0.8995174544264155,0.5488575595527467,0.058122270844032924,"['ARHGDIG', 'CELSR2', 'LY6E']",0.9990754180361097,0,0,3
349,Mesodermal commitment pathway WP2857,0.8995174544264155,0.5488575595527467,0.058122270844032924,"['PRKAR1A', 'NABP2', 'RPL38']",0.9990754180361097,0,0,3
350,Apoptosis Modulation and Signaling WP1772,0.9045155733540643,0.5747419395947496,0.05767866223023464,"['ENDOG', 'BAD', 'CYCS', 'BAX']",0.9990754180361097,0,0,4
351,ATM Signaling Network in Development and Disease  WP3878,0.912711619805141,0.402846975088968,0.03679415266655687,['IKBKG'],0.9990754180361097,0,0,1
352,Nuclear receptors WP170,0.912711619805141,0.402846975088968,0.03679415266655687,['NR2F6'],0.9990754180361097,0,0,1
353,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.912711619805141,0.402846975088968,0.03679415266655687,['BAX'],0.9990754180361097,0,0,1
354,RANKL/RANK signaling pathway WP2018,0.912711619805141,0.402846975088968,0.03679415266655687,['IKBKG'],0.9990754180361097,0,0,1
355,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.912711619805141,0.402846975088968,0.03679415266655687,['RPS6'],0.9990754180361097,0,0,1
356,Vitamin D-sensitive calcium signaling in depression WP4698,0.912711619805141,0.402846975088968,0.03679415266655687,['GPX4'],0.9990754180361097,0,0,1
357,Zinc homeostasis WP3529,0.912711619805141,0.402846975088968,0.03679415266655687,['MT3'],0.9990754180361097,0,0,1
358,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9154005086008389,0.4736263160651616,0.04186553283830897,"['SOCS3', 'STMN1']",0.9990754180361097,0,0,2
359,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9293072782793945,0.44721480162263777,0.032787925463844084,"['CAP1', 'HRAS']",0.9990754180361097,0,0,2
360,IL-1 signaling pathway WP195,0.9300855554095753,0.3661436428340343,0.02653761597891754,['IKBKG'],0.9990754180361097,0,0,1
361,Microglia Pathogen Phagocytosis Pathway WP3937,0.9300855554095753,0.3661436428340343,0.02653761597891754,['RAC3'],0.9990754180361097,0,0,1
362,Oxysterols derived from cholesterol WP4545,0.9300855554095753,0.3661436428340343,0.02653761597891754,['ACOT4'],0.9990754180361097,0,0,1
363,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9300855554095753,0.3661436428340343,0.02653761597891754,['HRAS'],0.9990754180361097,0,0,1
364,TGF-beta Receptor Signaling WP560,0.9300855554095753,0.3661436428340343,0.02653761597891754,['HRAS'],0.9990754180361097,0,0,1
365,Allograft Rejection WP2328,0.9410327593358189,0.4235834465951165,0.025744269510342126,"['HLA-B', 'HLA-DRB1']",0.9993428989491172,0,0,2
366,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9591680579151415,0.3830725522622228,0.015969902659319756,"['HMGCS1', 'CALM2']",0.9993428989491172,0,0,2
367,Endochondral Ossification WP474,0.9591680579151415,0.3830725522622228,0.015969902659319756,"['HMGCS1', 'CALM2']",0.9993428989491172,0,0,2
368,T-cell receptor (TCR) signaling pathway WP69,0.9591680579151415,0.3830725522622228,0.015969902659319756,"['IKBKG', 'HRAS']",0.9993428989491172,0,0,2
369,Vitamin A and carotenoid metabolism WP716,0.9640839616761401,0.2874936451448907,0.010515623718756806,['CYP26B1'],0.9993428989491172,0,0,1
370,Complement system WP2806,0.9657745464655084,0.45907990314769975,0.015987393705325915,"['FKBP2', 'RPS19', 'CD59', 'TXN']",0.9993428989491172,0,0,4
371,Peptide GPCRs WP24,0.9660958911173863,0.3655792115275642,0.012609625258436976,"['OPRL1', 'HCRTR1']",0.9993428989491172,0,0,2
372,Osteoblast differentiation WP4787,0.9718852707684841,0.3496070308567889,0.009969923983277068,"['NOTCH4', 'DLL3']",0.9993428989491172,0,0,2
373,NRF2 pathway WP2884,0.9743368352950191,0.4666735880398671,0.01213267716504388,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'FTL']",0.9993428989491172,0,0,5
374,Monoamine GPCRs WP58,0.976967187528402,0.25144572953736655,0.005859241803846102,['HTR5A'],0.9993428989491172,0,0,1
375,Pathways Regulating Hippo Signaling WP4540,0.976967187528402,0.25144572953736655,0.005859241803846102,['PRKAR1A'],0.9993428989491172,0,0,1
376,Phosphodiesterases in neuronal function WP4222,0.976967187528402,0.25144572953736655,0.005859241803846102,['PDE6G'],0.9993428989491172,0,0,1
377,Toll-like Receptor Signaling Pathway WP75,0.976967187528402,0.25144572953736655,0.005859241803846102,['IKBKG'],0.9993428989491172,0,0,1
378,Spinal Cord Injury WP2431,0.9785133950757959,0.4225550495328419,0.009178234920733294,"['BCAN', 'GADD45A', 'APEX1', 'OMG']",0.9993428989491172,0,0,4
379,Ciliopathies WP4803,0.9803766584118982,0.3765040106951872,0.0074617205798409485,"['NEK2', 'CCNQ', 'CCDC28B']",0.9993428989491172,0,0,3
380,AMP-activated protein kinase (AMPK) signaling WP1403,0.9852314461768096,0.22340846184262556,0.00332402629122615,['CCNB1'],0.9993428989491172,0,0,1
381,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9852314461768096,0.22340846184262556,0.00332402629122615,['ACTG1'],0.9993428989491172,0,0,1
382,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9852314461768096,0.22340846184262556,0.00332402629122615,['YWHAQ'],0.9993428989491172,0,0,1
383,Regulation of toll-like receptor signaling pathway WP1449,0.9868581651747604,0.2975495531150028,0.003936269005329934,"['CUEDC2', 'IKBKG']",0.9993428989491172,0,0,2
384,Nuclear Receptors Meta-Pathway WP2882,0.9877125529758147,0.5300015141355368,0.006552706499871985,"['PSMC5', 'GADD45B', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'FTL']",0.9993428989491172,0,0,11
385,Wnt signaling pathway and pluripotency WP399,0.9881747661805234,0.21160329649747145,0.0025171710334406976,['PPM1J'],0.9993428989491172,0,0,1
386,ESC Pluripotency Pathways WP3931,0.9924192768097148,0.19136587019149295,0.001456218284161027,['HRAS'],0.9993428989491172,0,0,1
387,Glucocorticoid Receptor Pathway WP2880,0.9924192768097148,0.19136587019149295,0.001456218284161027,['GADD45B'],0.9993428989491172,0,0,1
388,Complement and Coagulation Cascades WP558,0.9961097376040516,0.16733392645314354,0.0006522424028916347,['CLTC'],0.9993428989491172,0,0,1
389,Vitamin D Receptor Pathway WP2877,0.9970248125416805,0.32028545941124,0.0009543296417186873,"['CDKN2D', 'GADD45A', 'S100A6', 'HLA-DRB1']",0.9993428989491172,0,0,4
390,"GPCRs, Class A Rhodopsin-like WP455",0.9989138593591428,0.3422443508234393,0.00037192751791295165,"['MAS1', 'GPR22', 'APLNR', 'OPRL1', 'HTR5A', 'HCRTR1']",0.9993428989491172,0,0,6
391,"GPCRs, Other WP117",0.9993428989491172,0.12527802491103202,8.234738006052942e-05,['CELSR2'],0.9993428989491172,0,0,1
